BION
Bion Environmental Technologies provides environmental solutions to Concentrated Animal Feeding Operations (CAFO's). The Company's technology reduces excess nutrients from CAFO waste that fuel toxic algae blooms and dead zones in the Chesapeake Bay, Gulf of Mexico, and the Great Lakes. It was founded in 1989 and headquartered in Crestone, Colorado.
BION
Industry:
Agriculture Biotechnology Environmental Consulting Health Care Information Technology Livestock
Founded:
1989-01-01
Address:
Crestone, Colorado, United States
Country:
United States
Website Url:
http://www.biontech.com
Total Employee:
11+
Status:
Active
Contact:
(212)758-6622
Total Funding:
890 K USD
Technology used in webpage:
ReCAPTCHA ReCAPTCHA V2 ReCAPTCHA V3 3 To 9 CcTLD Redirects
Current Employees Featured
Founder
Stock Details
Official Site Inspections
http://www.biontech.com Semrush global rank: 532.8 K Semrush visits lastest month: 90.53 K
- Host name: a23-212-251-13.deploy.static.akamaitechnologies.com
- IP address: 23.212.251.13
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Bion"
From Discovery to Delivery โ Meet our Senior Team - BioNTech
Having joined BioNTech in 2019, the year in which BioNTech went public, Lisa has since played a key role in building, expanding and professionalizing the finance organization. She has been โฆSee details»
BioNTech | Our mission: basic research in mRNA โฆ
BioNTech works closely with some of the worldโs most established pharmaceutical companies and non-profit organizations to drive breakthroughs in medical science, therapeutical innovations, and improvement of quality of โฆSee details»
BioNTech - Wikipedia
BioNTech was founded in 2008 based on research by Uฤur ลahin, Özlem Türeci, [8] and Christoph Huber, [9] with a seed investment of โฌ180 million [10] from MIG Capital, a Munich โฆSee details»
Management Report on the Group and the Company for the 2020 โฆ
BioNTech Org Chart + Executive Team - The Official Board
Organizational Chart of BioNTech. BioNTech Org Chart www.biontech.de. has 42 executives and 3 subsidiaries +49 613 190 840; Add an executive. BioNTech (BNTX) News . Anything โฆSee details»
BioNTech - Crunchbase Company Profile & Funding
BioNTech creates protein-based therapeutics, including antibodies and antibody-drug conjugates, to address various tumor types and bacterial infections. Small Molecule Immunomodulators BioNTech develops small molecules to enhance โฆSee details»
BioNTech - The Org
BioNTech was founded in 2008 on the understanding that every cancer patientโs treatment should be individualized. Their vision is to provide patient-specific immunotherapies worldwide. โฆSee details»
Overview - BioNTech
BioNTech SE. An der Goldgrube 12. 55131 Mainz, Germany. T: +49 6131 9084-0. F: +49 6131 9084-2121. [email protected]. Footer Social Links. Twitter. Linkedin. Company. About โฆSee details»
BioNTech Announces Appointment of Ramón Zapata to โฆ
Mainz, Germany, May 5, 2025 (GLOBE NEWSWIRE) โ BioNTech SE (Nasdaq: BNTX, โBioNTechโ or โthe Companyโ) announced today that the Supervisory Board has appointed โฆSee details»
BioNTech SE Company Profile - Overview - GlobalData
BioNTech SE (BioNTech) is a biotechnology company that develops immunotherapies for cancer and infectious diseases. The company's primary activities involve harnessing the immune โฆSee details»
BioNTech | Global Health Commitment
BioNTech aspires to translate science into survival by addressing pressing health challenges we face as a global society. Based on our mRNA technology and our experience in the field of โฆSee details»
BioNTech | Our Commitment
At BioNTech, we want to improve the quality of care for people. In accordance with this mission, we ensure that all trials and clinical research activities meet or exceed international ethical and โฆSee details»
BioNTech Announces Appointment of Ramón Zapata to โฆ
May 5, 2025 He will join BioNTech from Novartis AGโ s global biomedical research organization where he has been serving as CFO since 2022. Ramón Zapata will succeed Jens Holstein, โฆSee details»
BioNTech Clinical Trials | Advancing Health Through Innovation
At BioNTech, we are committed to improving the health of people worldwide by developing novel medicines to address cancer, infectious diseases and other serious diseases. Clinical trials are โฆSee details»
BioNTech Company Profile - Office Locations, Competitors ... - Craft
Oct 29, 2024 BioNTech has 5 employees across 22 locations and โฌ2.75 b in annual revenue in FY 2024. See insights on BioNTech including office locations, competitors, revenue, financials, โฆSee details»
Transparency - BioNTech
Patient Organization Reporting BioNTech is determined to improve the healthcare and well-being of people globally through fundamental research and development of immunotherapies. We โฆSee details»
BioNTech Announces First Quarter 2025 Financial Results and
May 5, 2025 BioNTech expects its revenues for the full 2025 financial year to be in the range of โฌ1,700 - โฌ2,200 million and revenue phasing similar to 2024, primarily concentrated in the last โฆSee details»
BioNTech: A company with social responsibility
BioNTech was again awarded "Prime" status by the internationally recognized rating agency ISS ESG in 2024, placing it in the top 10% of all companies rated in the Pharmaceuticals and โฆSee details»
BioNTech says Novartis executive Zapata-Gomez to become CFO
May 5 (Reuters) - German COVID-19 vaccine maker BioNTech (22UAy.DE), opens new tab said on Monday that Ramon Zapata-Gomez will become its new finance chief from July 1. Zapata โฆSee details»
5 years later: What happened to COVID vaccine companies?
May 2, 2025 BioNTech. Alongside Moderna, BioNTech helped bring mRNA technology into the public eye during the pandemic. Partnering with Pfizer, the German biotech developed one of โฆSee details»